OBE Obsidian Energy Ltd. Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
13:41
Sep 15
u/Provolone-Jones Reddit r/wallstreetbets
Buy OBE dip as top pure oil play
The author argues OBE is one of the best pure oil plays yet is trading red, and frames the weakness as a buying opportunity. The implied mechanism is that the selloff is unjustified relative to its oil exposure, so a re-rating could follow once sentiment normalizes. No specific catalyst or time horizon is given, and the main risk is that the decline reflects a fundamental problem rather than a temporary dip.
OBE 1ST
MED
11:42
Jun 04
seedy19tron Biotech trader, L/S
The author argues that miR-124 induction does not weaken the intestinal barrier in UC.
The author argues that miR-124 induction does not weaken the intestinal barrier in UC, citing strong mucosal healing data to counter the parent's concern.
OBE
LOW
03:08
Jun 02
seedy19tron Biotech trader, L/S
Author argues Obe's superior safety data and novel MOA make it a better long-term bet than.
Author argues Obe's superior safety data and novel MOA make it a better long-term bet than Rinvoq, citing BP acquisition precedent for novel mechanisms.
OBE
02:49
Jun 02
seedy19tron Biotech trader, L/S
The author argues that Obe's split-label induction/maintenance dosing structure is the likely.
The author argues that Obe's split-label induction/maintenance dosing structure is the likely approval path, but does not state a personal position or forward call.
OBE
LOW
12:21
May 11
seedy19tron Biotech trader, L/S
The author analyzes Obe's pharmacokinetics and trial mechanics to estimate a 25-35pp.
The author analyzes Obe's pharmacokinetics and trial mechanics to estimate a 25-35pp active-placebo delta, aligning with management's 25-30% guidance.
OBE
HIGH

About OBE Investor Commentary

Across the available history and selected sources, Buzzberg tracks OBE (Obsidian Energy Ltd.) across 2 sources: 1 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 20% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 5 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/Provolone-Jones, seedy19tron.